Blog
Latest articles, insights, and updates from the blog.
Does Ketamine Work for Anxiety?
Emerging evidence suggests low-dose ketamine can reduce anxiety symptoms, with several studies showing rapid anxiolytic effects alongside its antidepressant properties.
Low-Dose Ketamine for Chronic Pain Syndromes
A clinical review of subanesthetic ketamine infusion therapy for chronic pain conditions including complex regional pain syndrome, fibromyalgia, and neuropathic pain, covering mechanisms, protocols, and evidence.
Low-Dose Ketamine for Bipolar Depression: Efficacy and Safety Data
Comprehensive review of low-dose ketamine for bipolar depression, examining clinical trial efficacy, safety profiles, and rapid-acting antidepressant mechanisms in bipolar disorder.
Low-Dose Ketamine for Anxiety Disorders
A clinical overview of subanesthetic ketamine's therapeutic potential in generalized anxiety disorder, social anxiety disorder, and obsessive-compulsive disorder, including mechanistic pathways, current evidence, and considerations for clinical practice.
Ketamine vs Traditional Antidepressants: Mechanism, Efficacy, and Clinical Role
Comprehensive comparison of ketamine therapy versus traditional antidepressants (SSRIs, SNRIs, TCAs) for depression, covering onset of action, mechanisms, efficacy in treatment-resistant depression, side effects, cost, and access.
Sublingual vs Oral (Swallowed) Ketamine: Absorption and Efficacy Differences
Detailed comparison of sublingual and oral (swallowed) ketamine administration routes, covering bioavailability differences, onset of action, first-pass metabolism, dosing strategies, taste considerations, and clinical outcomes.
Ketamine vs TMS (Transcranial Magnetic Stimulation): Two Approaches to Treatment-Resistant Depression
Evidence-based comparison of ketamine therapy and transcranial magnetic stimulation (TMS) for treatment-resistant depression, examining mechanisms, treatment protocols, efficacy, side effects, FDA approval status, cost, and convenience.
IV vs Oral Ketamine: Routes of Administration Compared
Clinical comparison of intravenous and oral ketamine for depression and pain, examining bioavailability, efficacy evidence, convenience, cost, monitoring requirements, and appropriate clinical settings.
IV Racemic Ketamine vs Esketamine (Spravato): A Clinical Comparison
Evidence-based comparison of IV racemic ketamine and intranasal esketamine (Spravato) for treatment-resistant depression, examining mechanism differences, efficacy data, FDA status, cost, access, and side effects.
Telemedicine Monitoring Protocols for At-Home Ketamine Therapy
Evidence-based guidance on remote monitoring protocols for at-home ketamine administration, covering vital sign monitoring, telehealth check-ins, safety frameworks, and technology requirements.
Measuring Ketamine Treatment Outcomes: Validated Assessment Tools
Review of validated assessment tools for measuring ketamine treatment outcomes, covering depression rating scales, suicidality measures, functional assessments, and biomarkers.
Telehealth Ketamine Marketing Compliance: Regulatory and Ethical Guidelines
Regulatory guide for marketing at-home ketamine therapy and esketamine services, covering FDA rules, DEA requirements, and state telemedicine laws.
Ready to learn more?
Explore our comprehensive guides and tools to help you navigate your ketamine therapy journey.